Hao, Zhenwen
Wang, Zhiming
Ma, Jinfeng
Li, Yifan
Zhang, Wenbin
Funding for this research was provided by:
the Science and Education Cultivation Fund of the National Cancer and Regional Medical center of Shanxi Provincial Cancer hospital (SD2023005, SD2023005)
Article History
Received: 23 October 2024
Accepted: 4 June 2025
First Online: 23 June 2025
Declarations
:
: This retrospective study utilized clinical data collected for clinical purposes. Extensive consultation with the Ethics Committee of Shanxi Cancer Hospital was conducted, and ethical approval was granted by the Ethics Committee of Shanxi Cancer Hospital (No: 2022JC23). All methods were carried out following relevant guidelines and regulations. The procedures involving human participants complied with ethical standards set by our institutional research committee. Informed consent was obtained from all patients, indicating their voluntary and informed agreement to participate in the study. Patients also provided written consent for publication and any accompanying images. A copy of the consent form is available for review by the journal's Editor-in-Chief upon request [, ].
: Not Applicable.
: The authors declare no competing interests.
: Our study has been officially recorded on the Research Registry under the identifying number Research Registry 9867 ().